ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: PD51632 was a slight outlier to these trends, having had treatment for colorectal cancer with chemotherapy in the preceding 8 months before CML diagnosis, which may have enhanced selection on BCR::ABL1-positive HSPCs.